PCLAF and breast carcinoma: This is consistent with previous studies showing that KIAA0101 overexpression is often correlated with tumoral grade and lower survival in hepatocellular carcinoma (52), human non-small cell lung cancer (53), adrenocortical tumors (54), gastric cancer (55), and breast cancer (56).